The combination of effects can lead to reduced calorie intake and, over time, significant weight loss
What I want patients and clinicians to take away from this is that if you or your patient has obesity, established cardiovascular disease, type 2 diabetes, CKD, HFpEF, MASH, or sleep apnea, this drug class should be a serious part of the treatment conversation
Dunaif A (2016) Perspectives in polycystic ovary syndrome: From hair to eternity
Week-by-Week Progress: Your First Month on GLP-1 Week 1: Adjusting to GLP-1 Treatment During the first week, your body starts adapting to the medication
These drugs are dominating conversations and represent the next generation of weight loss wars, offering results once thought possible only through surgery
& Carpenter, C